Table 1. Patient characteristics at baselinea
n or Mean | % or SD | |
---|---|---|
a EPO, erythropoietin; BMI, body mass index; nPNA, nPCR, normalized protein catabolic rate. | ||
b To convert from g/dl to g/L, multiply by 10. | ||
c To convert from g/dl to mmol/L, multiply by 0.25; to mEq/L, multiply by 0.5. | ||
d To convert from g/dl to mmol/L, multiply by 0.323. | ||
Age (yr; n [%]) | ||
<45 | 89 | 12.0 |
45 to 60 | 185 | 25.0 |
60 to 70 | 203 | 27.4 |
>70 | 263 | 35.5 |
Gender (n [%]) | ||
male | 425 | 57.4 |
female | 315 | 42.6 |
Primary kidney disease (n [%]) | ||
Diabetes | 111 | 15.0 |
Glomerulonephritis | 76 | 10.3 |
Renal vascular cause | 157 | 21.2 |
All other | 396 | 53.5 |
Davies’ comorbidity score (n [%]) | ||
no | 296 | 40.0 |
intermediate | 361 | 48.8 |
high | 83 | 11.2 |
SGA score (n [%]) | ||
≤4 | 108 | 14.6 |
5 | 138 | 18.7 |
6 | 282 | 38.1 |
7 | 212 | 28.7 |
No. of patients treated with EPO (n [%]) | 669 | 90.4 |
Albumin (g/dlb; mean [SD]) | 3.66 | 0.48 |
Hemoglobin (g/dlb) | 10.7 | 1.4 |
BMI (kg/m2) | 24.6 | 4.5 |
nPCR (g/kg per d) | 1.00 | 0.23 |
Calcium (mg/dl)c | 9.36 | 1.0 |
Phosphorus (mg/dl)d | 5.85 | 1.76 |
Systolic BP (mmHg, before/after session) | 154/142 | 21/21 |
Diastolic BP (mmHg, before/after session) | 82/78 | 11/11 |